How the Microbiome Influences Adrenal Health
Aug 14, 2024
We ensure our content is always unique, unbiased, supported by evidence. Each piece is based on a review of research available at the time of publication and is fact-checked and medically reviewed by a topic expert.
Written by: Kyla Reda
Medically reviewed by: Lara Zakaria PharmD, CNS, IFMCP
The gut-brain axis is a bidirectional communication network that highlights the importance of gut health in regulating the body’s stress response and adrenal function. Keep reading to learn about the role of the microbiome and how to approach laboratory analysis comprehensively to support your patients.
The gut microbiome consists of trillions of microorganisms that play a crucial role in endocrine functions, including the adrenal glands. (Rusch 2023) The adrenal glands produce hormones such as cortisol, which is vital for the stress response.
A healthy gut microbiome supports the adrenal glands by regulating the hypothalamic-pituitary-adrenal (HPA) axis, the central stress response system. (Rusch 2023) Beneficial gut bacteria produce short-chain fatty acids (SCFAs) like butyrate, which have anti-inflammatory properties and help maintain the integrity of the gut lining. (Shin 2023) A robust gut lining prevents endotoxins from entering the bloodstream and triggering systemic inflammation, which can dysregulate the HPA axis and impair adrenal function. (Mohammad 2021)(Ahmad 2021)
However, an imbalance in the gut microbiome, known as dysbiosis, can disrupt the HPA axis. Dysbiosis often leads to increased intestinal permeability, commonly referred to as "leaky gut." This condition allows harmful substances to pass into the bloodstream, causing chronic low-grade inflammation and placing additional stress on the adrenal glands. (Aleman 2023) Over time, chronic stress and inflammation can lead to adrenal fatigue or dysfunction, impairing the body's ability to respond effectively to stress. (Hannibal 2014)
Both weight gain and weight loss can be associated with cortisol level imbalances.
Cortisol, the primary stress hormone produced by the adrenal glands, plays a critical role in regulating metabolism, the immune response, and inflammation. The gut microbiome influences cortisol production through various mechanisms. For instance, certain gut bacteria can produce neurotransmitters like gamma-aminobutyric acid (GABA) and serotonin, which modulate the HPA axis and cortisol secretion. (Rusch 2023)
Dysbiosis can lead to altered cortisol levels, either by increasing or decreasing its production. (Rusch 2023) Over time, chronic stress and elevated cortisol levels are associated with various health issues, including hypertension, insulin resistance, weight gain, heart attack, stroke, diabetes, and neurological problems like memory loss and mood changes. (NIDDK 2023) On the other hand, decreased cortisol levels can cause weight loss, chronic fatigue, muscle weakness, and loss of appetite. (NIDDK 2022)
Inflammation is another critical aspect influenced by the microbiome. A healthy gut microbiome produces anti-inflammatory metabolites, helping to regulate the body's inflammatory response. Dysbiosis disrupts this balance, leading to increased production of pro-inflammatory cytokines. (CDC 2024) Chronic inflammation can damage the body’s glucocorticoid receptor, increasing cortisol dysfunction. (Hannibal 2014)
Recognizing the signs of microbiome imbalance is essential for identifying potential impacts on adrenal health.
The gut-brain axis plays a crucial role in mental health. Dysbiosis can affect neurotransmitter production, leading to symptoms of anxiety, depression, and mood swings. (Clapp 2017) These symptoms often coexist with adrenal dysfunction. (NIDDK 2022)
Persistent digestive problems such as bloating, gas, diarrhea, constipation, and food intolerances often indicate gut dysbiosis. (Wei 2021) These issues can signal an imbalance in gut bacteria, affecting nutrient absorption and overall gut health.
Chronic fatigue is a hallmark symptom of adrenal dysfunction. (NIDDK 2022) Dysbiosis can contribute to fatigue by disrupting cortisol production, altering circadian rhythm, impacting sleep quality, increasing inflammation, and impairing nutrient absorption. (Rusch 2023)
Since the gut and microbiome balance play a significant role in immune system balance, a compromised gut microbiome weakens the immune system, making those with dysbiosis more susceptible to infections. Frequent colds, flu, and other infections can indicate both gut and adrenal health issues. (Wiertsema 2021)
Conditions such as acne, eczema, and psoriasis can be linked to gut dysbiosis and chronic inflammation, both of which affect adrenal health. (Widhiati 2021) Stress can also exacerbate skin reactions. (Lambert 2022)
Several conditions are associated with both gut dysbiosis and adrenal dysfunction, highlighting the interconnectedness of these systems.
Conditions such as rheumatoid arthritis, lupus, and inflammatory bowel disease (IBD) involve chronic inflammation and immune dysregulation. (Xiang 2023) Both dysbiosis and adrenal dysfunction can exacerbate these conditions by perpetuating inflammation and stress.
Chronic fatigue syndrome (CFS) is a complex disorder involving severe fatigue and other symptoms. (CDC 2024) Dysbiosis and adrenal dysfunction are frequently observed in individuals with CFS, suggesting a multifactorial etiology involving gut health and stress response. (Deumer 2021)
Chronic fatigue is linked to both gut dysbiosis and adrenal dysfunction.
This condition is characterized by widespread musculoskeletal pain and fatigue. Similar to CFS, fibromyalgia patients are often found to have dysbiosis and HPA axis abnormalities, implicating gut-adrenal interactions. (Clos-Garcia 2019)
Irritable bowel syndrome (IBS) is a common condition characterized by chronic digestive issues. It's often associated with dysbiosis and has been linked to abnormal cortisol levels and HPA axis dysfunction. (Shaikh 2023)
Accurate diagnosis is crucial for addressing microbiome imbalances and adrenal dysfunction. Various diagnostic tests can provide valuable insights to help support patient outcomes.
Comprehensive hormone panels, including blood or saliva tests, evaluate adrenal hormones (cortisol, DHEA) and sex hormones (estrogen, progesterone, testosterone). These tests help assess overall endocrine function and identify imbalances affecting adrenal health. (NICHD 2017)
This test analyzes urine for organic acids, which are metabolic byproducts. It provides insights into gut dysbiosis, nutrient deficiencies, catecholamine markers, and mitochondrial function, helping to uncover underlying factors contributing to adrenal dysfunction. (Lord 2008)(Rogers 2006)
Salivary cortisol testing measures cortisol levels at different times of the day, providing a comprehensive view of adrenal function and circadian rhythm. It helps identify abnormal cortisol patterns associated with stress, adrenal fatigue, and HPA axis dysregulation. (Kobayashi 2017)(Langelaan 2018)
Comprehensive stool analysis evaluates the composition and function of the gut microbiome. It identifies beneficial and pathogenic bacteria, as well as yeast overgrowth. This test helps pinpoint dysbiosis and guides targeted interventions to restore gut health. (Alagiakrishnan 2024)
By recognizing the signs of microbiome imbalance and understanding its impact on adrenal function, healthcare providers can implement personalized treatment plans to restore gut health and support adrenal resilience in patients.
References
Ahmad, M. H., Rizvi, M. A., Fatima, M., & Mondal, A. C. (2021). Pathophysiological implications of neuroinflammation mediated HPA axis dysregulation in the prognosis of cancer and depression. Molecular and Cellular Endocrinology, 520, 111093. https://doi.org/10.1016/j.mce.2020.111093
Alagiakrishnan, K., Morgadinho, J., & Halverson, T. (2024). Approach to the diagnosis and management of dysbiosis. Frontiers in Nutrition, 11. https://doi.org/10.3389/fnut.2024.1330903
Aleman, R. S., Moncada, M., & Aryana, K. J. (2023). Leaky gut and the ingredients that help treat it: a review. Molecules, 28(2), 619. https://doi.org/10.3390/molecules28020619
Bander, Z. A., Nitert, M. D., Mousa, A., & Naderpoor, N. (2020). The Gut Microbiota and inflammation: An Overview. International Journal of Environmental Research and Public Health, 17(20), 7618. https://doi.org/10.3390/ijerph17207618
CDC. (2024) Symptoms of myalgic Encephalomyelitis/Chronic fatigue syndrome. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. https://www.cdc.gov/me-cfs/signs-symptoms/index.html
Clapp, M., Aurora, N., Herrera, L., Bhatia, M., Wilen, E., & Wakefield, S. (2017). Gut microbiota’s effect on mental health: The Gut-Brain axis. Clinics and Practice, 7(4), 987. https://doi.org/10.4081/cp.2017.987
Clos-Garcia, M., Andrés-Marin, N., Fernández-Eulate, G., Abecia, L., Lavín, J. L., Van Liempd, S., Cabrera, D., Royo, F., Valero, A., Errazquin, N., Vega, M. C. G., Govillard, L., Tackett, M. R., Tejada, G., Gónzalez, E., Anguita, J., Bujanda, L., Orcasitas, A. M. C., Aransay, A. M., . . . Falcón-Pérez, J. M. (2019). Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia. EBioMedicine, 46, 499–511. https://doi.org/10.1016/j.ebiom.2019.07.031
Deumer, U., Varesi, A., Floris, V., Savioli, G., Mantovani, E., López-Carrasco, P., Rosati, G. M., Prasad, S., & Ricevuti, G. (2021). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): an overview. Journal of Clinical Medicine, 10(20), 4786. https://doi.org/10.3390/jcm10204786
Hannibal, K. E., & Bishop, M. D. (2014). Chronic Stress, cortisol dysfunction, and pain: A Psychoneuroendocrine Rationale for Stress management in Pain Rehabilitation. Physical Therapy, 94(12), 1816–1825. https://doi.org/10.2522/ptj.20130597
Kobayashi, H., Song, C., Ikei, H., Park, B., Kagawa, T., & Miyazaki, Y. (2017). Diurnal changes in distribution characteristics of salivary cortisol and immunoglobulin A concentrations. International Journal of Environmental Research and Public Health, 14(9), 987. https://doi.org/10.3390/ijerph14090987
Lambert, A. (2022, December 21). Stress and eczema. National Eczema Society. https://eczema.org/information-and-advice/triggers-for-eczema/stress-and-eczema/
Langelaan, M. L. P., Kisters, J. M. H., Oosterwerff, M. M., & Boer, A. (2018). Salivary cortisol in the diagnosis of adrenal insufficiency: cost efficient and patient friendly. Endocrine Connections, 7(4), 560–566. https://doi.org/10.1530/ec-18-0085
Lord, R. S., & Bralley, J. A. (2008). Clinical applications of urinary organic acids. Part 2. Dysbiosis markers. Alternative Medicine Review, 13(4), 292–306. https://pubmed.ncbi.nlm.nih.gov/19152477
Mohammad, S., & Thiemermann, C. (2021). Role of metabolic endotoxemia in systemic inflammation and potential interventions. Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.594150
NICHD. (2017) How do health care providers diagnose adrenal gland disorders? National Institute of Child Health and Human Development. https://www.nichd.nih.gov/health/topics/adrenalgland/conditioninfo/diagnosed#:~:text=Blood%20and%20urine%20tests%20help,determining%20whether%20it%20is%20cancerous.
NIDDK. (2023).Cushing’s Syndrome. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/endocrine-diseases/cushings-syndrome
NIDDK. (2022). Symptoms & Causes of Adrenal Insufficiency & Addison’s Disease. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/endocrine-diseases/adrenal-insufficiency-addisons-disease/symptoms-causes
Rogers, S. A. (2006). Using organic acids to diagnose and manage recalcitrant patients. Alternative Therapies in Health and Medicine, 12(4), 44. https://pubmed.ncbi.nlm.nih.gov/16862742/
Rusch, J. A., Layden, B. T., & Dugas, L. R. (2023). Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis. Frontiers in Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1130689
Shaikh, S. D., Sun, N., Canakis, A., Park, W. Y., & Weber, H. C. (2023). Irritable Bowel Syndrome and the gut microbiome: A Comprehensive review. Journal of Clinical Medicine, 12(7), 2558. https://doi.org/10.3390/jcm12072558
Shin, Y., Han, S., Kwon, J., Ju, S., Choi, T., Kang, I., & Kim, S. (2023). Roles of Short-Chain fatty acids in inflammatory bowel Disease. Nutrients, 15(20), 4466. https://doi.org/10.3390/nu15204466
Wei, L., Singh, R., Ro, S., & Ghoshal, U. C. (2021). Gut microbiota dysbiosis in functional gastrointestinal disorders: Underpinning the symptoms and pathophysiology. JGH Open, 5(9), 976–987. https://doi.org/10.1002/jgh3.12528
Widhiati, S., Purnomosari, D., Wibawa, T., & Soebono, H. (2021). The role of gut microbiome in inflammatory skin disorders: a systematic review. Dermatology Reports. https://doi.org/10.4081/dr.2022.9188